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Purpose: The present study reflects the trend and growth of publications on COVID-19 viral 
disease spreading around the world. With the emergence of COVID-19 in Wuhan, China in 
December 2019, scholars started publishing their researches in form of different kind of 
publications.  
Methodology: The data has been extracted from the Scopus database using key TERMS Covid-
19 and corona virus 2019. 
Findings: During six month period around ten thousand publications are contributed by scientists 
around the globe.   The literature produced in different fields but highest output is made in the 
field of Medicine. BMJ and Journal of Medical Virology journals produced highest amount of 
research on COVID. Highest numbers of publications have been contributed by China based two 
institutions viz. Huazhong University of Science and Technology and Tongji Medical College, 
China. Mahase, E. of UK contributed maximum papers followed by Wiwanitkit, V. of China. 
Keywords: COVID-19, nCov, Coronavirus 2019, Bibliometrics, Research output, COVID 
Literature. 
 
1.  INTRODUCTION 
Nowadays almost whole world is fighting against Novel Coronavirus or COVID-19 and 
efforts are being done by all the scientists of the world to develop the vaccine to get rid of the 
disease. COVID-19 stands for  COronaVIrus Disease which emerged in the year 2019.  It is also 
popular by names of n Cov, Corona, Covid.  At the end of 2019, multiple patients reported with 
pneumonia of unknown origin in Wuhan city of China and the causes were linked to sea food 
and wet animal market in Wuhan. On sampling from lower respiratory tract Zhu, etal identified 
novel corona virus as source of infection.2 Corona virus is basically a RNA virus and till date 
seven corona viruses are identified namely:  
1. “229E (alpha coronavirus)  
2. NL63 (alpha coronavirus)  
3.  OC43 (beta coronavirus)  
4. HKU1 (beta coronavirus) 
5. MERS-CoV (the beta coronavirus that causes Middle East Respiratory Syndrome, or 
MERS)  
6. SARS-CoV (the beta coronavirus that causes Severe acute respiratory syndrome, or 
SARS)  
7. 2019 Novel Coronavirus (2019-nCoV)”.3,5 
“The pathogenic infectivity of nCov requires the binding of S1 subunit of the spike (S) to the 
human Angiontensin Converting Enzyme (ACE2). After binding with ACE2 recepter the 
virus penetrates in to the human cell that require cleavage of S1–S2 subunits to expose S2 for 
fusion to cell membrane via host proteases like cathepsins, cell surface transmembrane 
protease/serine (TMPRSS) proteases, furin, trypsin and factor Xa).1 
 
The nCov spreads primarily through contact with infected persons via respiratory 
droplets or nasal and oral discharge. Symptoms of Covid-19 include shortness of breath, fever, 
cough, weakness and diarrhea. . Sometimes it may more severe and may lead to pneumonia, 
difficulty in breathing and more rarely the disease can be fatal in older individual and people 
with preexisting medical conditions. 
“A real-time reverse transcription PCR (RT-PCR) assay was used as diagnostic methods 
to detect viral RNA by targeting a consensus RdRp region of pan β-CoV. Virus isolation from 
the clinical specimens was performed with human airway epithelial cells and Vero E6 and Huh7 
cell lines.”5 
COVID “has triggered an avalanche of scientific research, both within and outside the 
medical domain, in order to help communities overcome this challenge by minimizing its 
adverse impacts. Research on Coronaviruses in general dates back to 1960’s and the literature on 
this topic is quite well established. The sub-domain of this academic field of research focusing 
on COVID19, however, is understandably just an emerging and fast developing field”6.  In the 
present study effort has been made to highlight the total research output of six months i. e 
December 2019-May 2020 on COVID-19 along with other like prolific authors, institutions, 
keywords, countries, subjects, etc. 
2. OBJECTIVES OF THE STUDY 
The main objective of this study is to analyze the research output on COVID-19 produced 
by different scholars and scientists. The specific objectives are: 
1. To analyze the year-wise research output on COVID-19.  
2. To find subjects wise research output on COVID-19. 
3. To identify the most prolific authors conducted research on COVID-19. 
4. To study the top sources preferred by authors for publishing COVID-19 research. 
5. To know the top institutional research output on COVID-19. 
6.  To identify the top countries conducting research on COVID-19. 
7. To identify the top used keywords in research publications on COVID-19. 
 
3. METHODOLOGY  
Data for the present study has been extracted from World’s largest database of peer 
reviewed literature i.e. Scopus. The study covers data from December 2019 to May 2020 for the 
Pandemic disease ‘Covid-19’ spreading worldwide. Data obtained from Scopus on COVID-19 
was extracted using key words -COVID-19, Novel Corona virus Disease 2019. After exporting 
data from Scopus database to excel sheet, it was encircled in definite to summarize outputs and 
place into tabular form.  
 
4. DATA ANALYSIS AND FINDINGS 
4.1 Yearly Distribution of Research Publications on COVID-19 
Table 1 shows the year-wise distribution of research publications during the period under 
study.  In the year 2019 only a fewer publications appeared on COVID-19 during December 
2019 which increased drastically from 07 in 2019 to 9947 publications in 2020 till May. It may 
be due to as “On 29th Jan WHO declared nCov 2019 as public health emergency of international 
concern. The disease was christened as COVID 19 by WHO on 11th Feb 2020”3. It is also 
notable in table that highest citations (27806) were recorded in the year 2020 whereas in 2019 
only 16 citations were credited to 7 papers.  The table reflects that in a total period of 6 months 
of pandemic (Dec 2019-May 2020) a total of 9954 research publications were appeared at global 
level ACPP of which was 2.79. 
Table 1: Year-wise distribution of research literature on COVID 
Year TP TC ACPP 
2020 9947 27806 2.79 
2019 7 16 2.28 
Total 9954 27822 2.79 
(TP=Total Publications; TC=Total Citations; ACPP= Average Citation Per Paper) 
 
4.1 Subject-wise distribution of Research publications 
Subject-wise distribution of research publications on COVID-19 is clearly depicted in 
table 4.2. It is evident that majority of publications on COVID-19 were produced in the field of 
‘Medicine’ (68.74%) which was distantly followed by ‘Biochemistry, genetics and molecular 
biology’ (7.40%). ‘Immunology and microbiology’ contributed 828 publications (6.79%) 
whereas Social sciences contributed nearly half of it i.e. 388 (3.18%) publications. With a very 
small gap ‘Nursing’ and ‘Neuroscience’ contributed almost similar percentage of publications on 
the disease i.e. 373 (3.06%) and 355 (2.91%) respectively. ‘Pharmacology, toxicology and 
pharmaceutics’ field contributed 310 (2.54%) publications to its credit followed by 
‘Environmental science i.e. 245 (2.01%). Last but not the least ‘health professionals’ also 
contributed their ideas in 217(1.59%) publications for the awareness of public. ‘Psychology’ 
discipline at 10th position contributed 194(1.59%) papers. 
Table 2:  Subject wise publication output 
Subject TP Percentage (%) 
Medicine 8384 68.74 
Biochemistry, Genetics and Molecular Biology 902 7.40 
Immunology and Microbiology 828 6.79 
Social Sciences 388 3.18 
Nursing 373 3.06 
Neuroscience 355 2.91 
Pharmacology, Toxicology and Pharmaceutics 310 2.54 
Environmental Science 245 2.01 
Health Professions 217 1.78 
Psychology 194 1.59 
Total 12196 100.00 
  
4.3 Type of Research Publications 
Nearly half of the research output on Covid-19 was published in the form of articles i.e. 
49.81%, followed by letters (21.05%). The next type was the editorial notes (10.28%) followed 
by review, note, short survey, erratum, conference paper and finally data papers i.e. 8.74%, 
8.00%, 1.07%, 0.5%, 0.42%, and 0.09% respectively.  
 
Table 3:  Type of publications 
Type TP Percentage (%) 
Article 4959 49.81 
Letter 2096 21.05 
Editorial 1024 10.28 
Review 870 8.74 
Note 797 8.00 
Short Survey 107 1.07 
Erratum 50 .50 
Conference Paper 42 .42 
Data Paper 9 .09 
Total 9954 100.00 
 
4.4 Preferred Sources for Publications on COVID-19 
Top twenty sources preferred for publications on COVID-19 are listed in table 4. These 
twenty sources published nearly 1725(17.32%) publications during six months. It is very 
apparent from table 4 that BMJ Clinical Research Ed has published maximum articles i.e. 
12.81%, followed by Journal of Medical Virology (11.36%).  A very small gap was there in BMJ 
and Lancet regarding the publications i.e. 7.94% & 7.59% respectively followed by Infection 
Control and Hospital epidemiology (5.04%). Psychiatry Research at 20th position published 
2.84%. It is also found that publications on COVID-19bwere published in many Impact factor 
journals. There were 3.42 percent publications published in highest IF journal New England 
Journal of Medicine (IF-70.670), Lancet (IF-59.102) and Journal of The American Medical 
Association (IF-51.273).  
It is notable that majority of the journals belongs to medicinal and disease and perfectly 
matches with COVID-19 disease. 
Table 4:  Top twenty sources published on COVID- 19 
Sources Publisher Country TP Percentage TR-IF 
(%) 2019 
BMJ Clinical Research 
Ed 
BMJ Pub. Group UK 221 12.81 - 
Journal of Medical 
Virology 
John Wiley & 
Sons 
USA 196 11.36 2.049 
BMJ BMJ Pub. Group UK 137 7.94 27.604 
Lancet Lancet Pub Group UK 131 7.59 59.102 




UK 87 5.04 2.856 
Journal of Infection 
W.B Saunders Co. 
Ltd 
UK 85 4.92 5.099 
Travel Medicine And 
Infectious Disease 
Elsevier BV Netherland 85 4.92 4.868 
Clinical Infectious 
Diseases 
Oxford Univ. Press UK 82 4.75 9.055 
Lancet Infectious 
Diseases 
Lancet Pub Group UK 73 4.23 27.516 
Science of The Total 
Environment 
Elsevier BV Netherland 71 4.11 5.589 





United States 68 3.94 51.273 
International Journal of 
Environmental Research 




Switzerland 60 3.47 2.468 








UK 58 3.36 1.740 
Brain Behavior and 
Immunity 
Elsevier Inc. United States 57 3.30 6.170 
International Journal of 
Infectious Diseases 






United States 52 3.01 3.489 
Journal of The 
American Academy of 
Dermatology 
Mosby Inc. United States 50 2.89 7.102 
Head and Neck 
John Wiley & 
Sons 
USA 49 2.84 2.442 
Psychiatry Research Elsevier B.V Netherland 49 2.84 2.208 
Total - - 1725 17.32 - 
(TR-IF: Thomson Reuter’s Impact Factor) 
4.5 Institutional Contribution on COVID-19 
Top twenty institutions that contributed highest research publications on COVID-19 
during the period under study are listed in table 5. These top institutions collectively contributed 
2470 (24.81%) publications on COVID-19. Highest numbers of publications among top twenty 
institutes were contributed by Huazhong University of Science and Technology (10.72%) and 
Tongji Medical College (10.64% publications). University at 20th position viz. Fudan University, 
contributed 85 publications. It is also apparent that out of top twenty institutions,  nine 
institutions  were from China. 
Hence it can be concluded that worldwide universities have participated for providing the 
literature on this pandemic disease COVID-19. 
Table 5: Research output of top twenty institutions 
Institutions Country TP 
Percentage 
(%) 
Huazhong University of Science and Technology China 265 10.72 
Tongji Medical College China 263 10.64 
Harvard Medical School USA 178 7.20 
Inserm Paris 139 5.62 
UniversitÃ  degli Studi di Milano Italy 130 5.26 
University of Toronto Canada 123 4.97 
University College London UK 120 4.85 
UniversitÃ  degli Studi di Roma La Sapienza Italy 120 4.85 
IRCCS Foundation Rome Italy 107 4.33 
University of Oxford UK 104 4.21 
Chinese Academy of Medical Sciences &amp; Peking 
Union Medical College 
China 103 4.17 
University of California, San Francisco USA 101 4.08 
The University of Hong Kong China 95 3.84 
Zhongnan Hospital of Wuhan University China 94 3.80 
Brigham and Women's Hospital USA 92 3.72 
Chinese University of Hong Kong China 89 3.60 
NHS Foundation Trust UK 88 3.56 
Wuhan University China 88 3.56 
Renmin Hospital of Wuhan University China 86 3.48 
Fudan University China 85 3.44 
Total  2470 24.81 
 
4.6 Most Prolific Authors  
The list of top seven authors who produced highest contribution to research output on 
COVID-19 s listed in Table 6. These top seven authors collectively published 183 papers on 
COVID-19. In terms of publications, Mahase, E. contributed maximum i.e. 48 papers followed 
by Wiwanitkit, V. (29) and Lippi, G. (28) respectively. Three authors have contributed exactly 
same number of publications i.e. 20 each for COVID-19. On the other hand, Goldust, M 
contributed 18 publications.  Lippi, G had higher H –index i.e 67 followed by Rodriguez-
Morales, A.J. (30). Out of top seven authors three were from UK. 
Table: 6 Top prolific authors 










China 29 5 
Lippi, Giuseppe 
 
Univ. of Verona, Italy 28 67 
Iacobucci, 
Gareth 
Medical Schools Council UK 20 1 




de Pereira, Pereira 






Hospital Basel, Basel 
Switzerland 18 14 
                                                                                                              183  
 
4.7Top Countries Research Contribution 
A research contribution of top twenty countries on COVID-19 is mentioned in Table.4.8. United 
States is on the first position with 2216 (22.26%) publications followed by China, Italy and 
United Kingdom in publications regarding COVID-19 and the corresponding values were 
1977(19.86) , 1162(11.67%) ,1002 (10.07%)  respectively. India’s share of contribution is at fifth 
position with 470 (4.72%) publications to its credit. Four countries France, Canada, Germany 
and Australia have contributed more 3 to 4 percent output on COVID. Next most contributing 
countries viz. Spain, Switzerland, Iran, Brazil and Singapore and Netherland which produced 
more than 2 percent publications on the disease. Another six top countries, Hong Kong, South 
Korea, Japan and Turkey also contributed remarkably. Hence it can be concluded that U.S., 
China, Italy, U.K. and India were more active countries in terms of publishing on COVID-19. 
Table: 7 Top twenty countries research contribution 
Top Countries TP Percentage (%) (N=9954) 
United States 2216 22.26 
China 1977 19.86 
Italy 1162 11.67 
United Kingdom 1002 10.07 
India 470 4.72 
France 433 4.35 
Canada 393 3.95 
Germany 383 3.85 
Australia 345 3.47 
Spain 296 2.97 
Switzerland 277 2.78 
Iran 258 2.59 
Brazil 216 2.17 
Singapore 214 2.15 
Netherlands 199 2.00 
Hong Kong 142 1.43 
South Korea 136 1.37 
Japan 134 1.35 
Turkey 130 1.31 
Belgium 126 1.27 
 
4.8 Most Preferred Keywords used for Research on COVID 
The most popular keywords that appeared in research publications on COVID-19 during period 
of six months are listed in table 8. The top fifteen keywords were appeared 27182 times in total 
publications published during the period under study. The frequently used keyword in the 
publications on nCov disease was COVID-19 used in 3235 papers followed by Human and 
coronavirus Disease 2019 i.e. in 2836, and 2355 papers respectively. On the other hand two 
terms Pandemic and coronavirus Infection used in similar number of papers i.e. 2100 and 2097 
respectively. Three related terms Virus Pneumonia, corona virus Infections, Pneumonia, viral 
and humans used in similar percentage i.e. 6.53%, 6.23% and 6.19 respectively. Another six 
terms Pandemics, Betacoronavirus, Severe Acute Respiratory Syndrome Coronavirus 2, 
Coronavirus, Priority Journal and SARS-CoV-2 were also used in publications and the 
corresponding number was 5.31%, 5.28%, 5.28%, 5.13%, 4.63%, and 4.14% respectively. Hence 
it can be said that keyword COVID-19 is popularly used in most of the papers globally. 
 
Table 8: Top 15 keywords used in publications on COVID-19 
Keywords Used TP Percentage (%) 
COVID-19 3235 11.90 
Human 2836 10.43 
Coronavirus Disease 2019 2355 8.66 
Pandemic 2100 7.72 
Coronavirus Infection 2097 7.71 
Virus Pneumonia 1776 6.53 
Corona virus Infections 1712 6.29 
Pneumonia, Viral 1683 6.19 
Humans 1646 6.05 
Pandemics 1445 5.31 
Betacoronavirus 1436 5.28 
Severe Acute Respiratory Syndrome 
Coronavirus 2 
1395 5.13 
Coronavirus 1259 4.63 
Priority Journal 1128 4.14 
SARS-CoV-2 1079 3.96 
Total 27182  
 
5. SUMMARY AND CONCLUSIONS 
The study focused on the six months (December 2019 –may 2020) research output on 
COVID-19 worldwide. It indicates that a total number of 9954 papers were published which has 
received 27822 citations during period under study. It was evident that medicine subject was on 
the top as COVID-19 is also a disease or we can say pandemic and the corresponding 
publications was 8384 i.e. 68.74% followed by biochemistry, genetics and molecular biology 
was 902 i.e. 7.40% only. Majority of the research publication was in the form of articles i.e. 
49.81%, followed by nearly half in the form of letter i.e. 21.05% reflect about COVID-19. The 
next type was in the editorial form i.e.10.28% followed by review, note, short survey, erratum, 
conference paper and finally data paper i.e. 8.74%, 8.00%, 1.07%, 0.5%, 0.42%, and 0.09% 
respectively. BMJ Clinical Research Ed has contributed maximum i.e. 12.81% maximum, 
followed by Journal of Medical Virology i.e. 11.36%. A very small gap was there in BMJ and 
Lancet regarding the publications i.e. 7.94% & 7.59% respectively followed by Infection Control 
and Hospital epidemiology contributed i.e. 5.04%. Total fifteen keywords constitute 27182 
publications to its credit. The frequently used word was COVID-19 i.e. 3235 times followed by 
Human and coronavirus Disease 2019 i.e. 2836, and 2355 respectively. The top ten institutions 
have contributed 2470 towards publication regarding COVID-19. It was also observed that 
among ten top Institutions which contributed highest research output on COVID-19 were 
Huazhong University of Science and Technology and Tongji Medical College i.e. 265 and 263 
publications. In terms of publications, Mahase, E. contributed maximum i.e. 48 followed by 
Wiwanitkit, V. Lippi, G. i.e. 29 and 28 respectively. Three authors have contributed exactly 
same number of publications i.e. 20 each for COVID-19. United States is on the first position 
with 2216 publications followed by China, Italy and United Kingdom in publications regarding 
COVID-19 and the corresponding value was 1977, 1162, 1002 respectively. India’s share of 
contribution is at fifth position with 470 publications to its credit. The study clearly reflects that 
research work on COVID-19 was very less in the last year or December 2019 but increased as 
COVID-19 becomes pandemic worldwide. Major research output took place in January 2020-
May 2020especially during spread of COVID-19. 
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